References
1. Packer DL, Mark DB, Robb RA et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest among Patients with Atrial Fibrillation: The CABANA Randomized Clinical Trial. In: JAMA - Journal of the American Medical Association . Vol 321. American Medical Association; 2019:1261-1274. doi:10.1001/jama.2019.0693
2. Steven D, Rostock T, Lutomsky B et al. What is the real atrial fibrillation burden after catheter ablation of atrial fibrillation? A prospective rhythm analysis in pacemaker patients with continuous atrial monitoring. Eur Heart J . 2008;29(8):1037-1042. doi:10.1093/eurheartj/ehn024
3. Packer DL, Kowal RC, Wheelan KR et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: First results of the North American arctic front (STOP AF) pivotal trial. J Am Coll Cardiol . 2013;61(16):1713-1723. doi:10.1016/j.jacc.2012.11.064
4. Nielsen JC, Johannessen A, Raatikainen P et al. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial.Heart . 2017;103(5):368-376. doi:10.1136/heartjnl-2016-309781
5. Mark DB, Anstrom KJ, Sheng S et al. Effect of Catheter Ablation vs Medical Therapy on Quality of Life among Patients with Atrial Fibrillation: The CABANA Randomized Clinical Trial. In: JAMA - Journal of the American Medical Association . Vol 321. American Medical Association; 2019:1275-1285. doi:10.1001/jama.2019.0692
6. Blomström-Lundqvist C, Gizurarson S, Schwieler J et al. Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients with Atrial Fibrillation: The CAPTAF Randomized Clinical Trial.JAMA - J Am Med Assoc . 2019;321(11):1059-1068. doi:10.1001/jama.2019.0335
7. Marrouche NF, Brachmann J, Andresen D et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med . 2018;378(5):417-427. doi:10.1056/NEJMoa1707855
8. Di Biase L, Mohanty P, Mohanty S et al. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial. In: Circulation . Vol 133. Lippincott Williams and Wilkins; 2016:1637-1644. doi:10.1161/CIRCULATIONAHA.115.019406
9. Calkins H, Kuck KH, Cappato R et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design. Heart Rhythm . 2012;9(4):632-696.e21. doi:10.1016/j.hrthm.2011.12.016
10. Wechselberger S, Kronborg M, Huo Y et al. Continuous monitoring after atrial fibrillation ablation: the LINQ AF study. EP Eur . 2018;20(FI_3):f312-f320. doi:10.1093/europace/euy038
11. Dinshaw L, Schäffer B, Akbulak Ö et al. Long-term efficacy and safety of radiofrequency catheter ablation of atrial fibrillation in patients with cardiac implantable electronic devices and transvenous leads. J Cardiovasc Electrophysiol . 2019;30(5):679-687. doi:10.1111/jce.13890
12. Heeger CH, Tscholl V, Salloum O et al. What is the real recurrence rate after cryoballoon-based pulmonary vein isolation? Lessons from rhythm follow-up based on implanted cardiac devices with continuous atrial monitoring. Hear Rhythm . 2018;15(12):1844-1850. doi:10.1016/j.hrthm.2018.07.016
13. Ferreira‐Martins J, Howard J, Al‐Khayatt B et al. Outcomes of paroxysmal atrial fibrillation ablation studies are affected more by study design and patient mix than ablation technique. J Cardiovasc Electrophysiol . 2018;29(11):1471-1479. doi:10.1111/jce.13745
14. Andrade JG, Champagne J, Dubuc M et al. Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial. Circulation . 2019;140(22):1779-1788. doi:10.1161/CIRCULATIONAHA.119.042622
15. Kaplan RM, Koehler J, Ziegler PD, Sarkar S, Zweibel S, Passman RS. Stroke risk as a function of atrial fibrillation duration and CHA2DS2-VASc score. Circulation . 2019;140(20):1639-1646. doi:10.1161/CIRCULATIONAHA.119.041303
16. Healey JS, Connolly SJ, Gold MR et al. Subclinical Atrial Fibrillation and the Risk of Stroke. N Engl J Med . 2012;366(2):120-129. doi:10.1056/NEJMoa1105575
17. Glotzer T V., Daoud EG, Wyse DG et al. The Relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk the trends study. Circ Arrhythmia Electrophysiol . 2009;2(5):474-480. doi:10.1161/CIRCEP.109.849638
18. Steinhubl SR, Waalen J, Edwards AM et al. Effect of a home-Based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation the mSToPS randomized clinical trial. JAMA - J Am Med Assoc . 2018;320(2):146-155. doi:10.1001/jama.2018.8102
19. Saglietto A, De Ponti R, Di Biase L et al. Impact of atrial fibrillation catheter ablation on mortality, stroke, and heart failure hospitalizations: A meta-analysis. J Cardiovasc Electrophysiol . Published online March 1, 2020. doi:10.1111/jce.14429
20. Jaïs P, Cauchemez B, Macle L et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: The A4 study.Circulation . 2008;118(24):2498-2505. doi:10.1161/CIRCULATIONAHA.108.772582
21. Calkins H, Reynolds MR, Spector P et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: Two systematic literature reviews and meta-analyses. Circ Arrhythmia Electrophysiol . 2009;2(4):349-361. doi:10.1161/CIRCEP.108.824789
22. Calkins H, Hindricks G, Cappato R et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Hear Rhythm . 2017;14(10):e275-e444. doi:10.1016/j.hrthm.2017.05.012
23. Boersma LVA, Castella M, Van Boven W et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): A 2-center randomized clinical trial. Circulation . 2012;125(1):23-30. doi:10.1161/CIRCULATIONAHA.111.074047
24. Di Biase L, Burkhardt JD, Mohanty P et al. Left Atrial Appendage Isolation in Patients With Longstanding Persistent AF Undergoing Catheter Ablation: BELIEF Trial. J Am Coll Cardiol . 2016;68(18):1929-1940. doi:10.1016/j.jacc.2016.07.770
25. Kuck K-H, Brugada J, Fürnkranz A et al. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med . 2016;374(23):2235-2245. doi:10.1056/NEJMoa1602014
26. Dulai R, Sulke N, Furniss S, Veasey RA. The effect of second-generation cryoablation without electrical mapping in persistent AF using continuous monitoring. J Interv Card Electrophysiol . Published online March 9, 2020. doi:10.1007/s10840-020-00721-1
27. Glotzer T V., Daoud EG, Wyse DG et al. The Relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk the trends study. Circ Arrhythmia Electrophysiol . 2009;2(5):474-480. doi:10.1161/CIRCEP.109.849638